Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence

Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study

(2010) P. Garnero et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Vertebral fracture assessment using a semiquantitative technique

(2010) Harry K. Genant et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures

(2010) V. Rabenda et al.   OSTEOPOROSIS INTERNATIONAL

Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis

(2009) François-Emery Cotté et al.   CLINICAL THERAPEUTICS

Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis

(2009) Pierre D Delmas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis

(2009) I. Imaz et al.   OSTEOPOROSIS INTERNATIONAL

Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women

(2008) Julie Blouin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization

(2008) J. A. Sunyecz et al.   OSTEOPOROSIS INTERNATIONAL

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis

(2008) P. Szulc et al.   OSTEOPOROSIS INTERNATIONAL